CAMPBELL, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced it will release its financial results for the fourth quarter and full year ended December 31, 2025, after market close on Thursday, February 12, 2026. Management will host a conference call on Thursday, February 12, 2026, at 4:30 PM ET to discuss these results. The call will be available, live, to interested parties by dialing: ...

Core Viewpoint - American Industrial Partners (AIP) has successfully acquired the Global Cellulose Fibers (GCF) business from International Paper, establishing GCF as an independent company [1][3]. Group 1: Company Overview - GCF is headquartered in Memphis, Tennessee, and is the leading global producer of high-quality absorbent fluff pulp for personal care applications, generating approximately $2.3 billion in revenue in 2024 [2][5]. - The company employs around 3,300 people and operates nine manufacturing facilities across the U.S., Canada, and Poland [2][5]. Group 2: Strategic Insights - AIP views GCF's strong market position, experienced workforce, and established customer relationships as key factors for future growth [3]. - GCF's CEO, Clay Ellis, emphasizes the alignment of AIP's long-term investment approach with GCF's culture and priorities, focusing on customer service and employee support [3]. Group 3: Transaction Details - BofA Securities served as the exclusive financial advisor to AIP and provided financing for the acquisition [3]. - Legal counsel for the transaction included Davis Polk & Wardwell LLP, Ropes & Gray LLP, and Baker Botts LLP [3]. Group 4: AIP Overview - AIP is an operationally-oriented industrials investor, focusing on quality industrial businesses with strong management teams and transformative Operating Agendas [4]. - The AIP portfolio companies generate approximately $29 billion in annual revenues and employ over 72,000 people as of September 30, 2025 [4].

Core Viewpoint - International Paper has successfully sold its Global Cellulose Fibers (GCF) business to American Industrial Partners for $1.5 billion, which includes preferred stock valued at $190 million [1]. Group 1: Business Overview - The GCF business produces high-quality pulp for various applications, including personal care products and construction materials, contributing to health and wellness [2]. - In 2024, the GCF segment generated $2.8 billion in revenue, with the sold operations accounting for approximately $2.3 billion, excluding revenue from closed mills [2]. - The GCF business employs 3,300 people globally and operates nine manufacturing facilities and eight regional offices [2]. Group 2: Company Background - International Paper is a leader in sustainable packaging solutions, headquartered in Memphis, Tennessee, with operations in over 30 countries and more than 65,000 employees [3]. - The company reported net sales of $18.6 billion for 2024 and acquired DS Smith in 2025, enhancing its position in the North American and EMEA markets [3].

Janac noted that Arteris acquired Magillem in 2020. He said Magillem addresses SoC connectivity definition, register management and hardware-software integration, and IP block packaging—tasks he said were historically managed with spreadsheets that no longer scale as chip connections increase.He said Arteris pioneered “network-on-chip” (NoC) technology, using networking techniques to move data inside semiconductor designs. According to Janac, Arteris NoC IP converts native protocols produced by IP blocks in ...

Arteris (NasdaqGM:AIP) FY Conference Summary Company Overview - **Industry**: Semiconductor IP - **Company**: Arteris IP - **Focus**: Data movement within semiconductor chips, utilizing network-on-chip (NoC) technology to enhance data processing, storage, and transfer capabilities [3][4] Core Business and Technology - **Products**: - Ncore: Cache-coherent product for processor subsystems - Non-coherent NoC IP: For data transport across chips - FlexGen: Automates NOC IP generation, improving design speed by 10x and reducing design length by up to 30% [9] - **Acquisitions**: - Magillem (2020): Enhances SoC connectivity and hardware-software integration - Cycuity (2023): Focuses on hardware security verification [14][15] Market Dynamics - **Increasing Complexity**: Driven by AI applications, chiplets, and the need for robust data movement solutions [5][6] - **AI Focus**: Approximately 50% of design starts are for AI applications, including automotive and data center solutions [10][11] - **Customer Base**: Over 230 active customers, including major global companies and startups [7][8] Financial Performance - **Third Quarter Highlights**: - Revenue growth of 18%, with a significant increase in remaining performance obligations (RPO) by 34% year-over-year, reaching approximately $105 million [19][20] - Positive free cash flow despite negative profitability due to deferred revenue model [17][18] - **Future Guidance**: - Projected revenue around $69 million for the upcoming year, with a target for license revenue growth in the high teens to low 20s percent [34] Growth Strategy - **R&D Investment**: Commitment to maintaining a robust R&D program, with plans to release one new product annually [13][30] - **Market Focus**: Targeting high-growth areas such as automotive, AI, and chiplet solutions [13][14] - **Inorganic Growth**: Potential for further acquisitions to enhance capabilities and market reach [22][23] Customer Relationships - **Retention Rate**: Over 90% customer retention, exemplified by a long-term relationship with Mobileye [12] - **Royalty Streams**: Diversification of royalty sources, with a significant portion now coming from automotive applications [26][27][28] Conclusion - Arteris is positioned for growth in the semiconductor IP market, leveraging its innovative technologies and strong customer relationships to navigate the complexities of modern chip design and data movement. The company is focused on maintaining financial health while investing in R&D and exploring strategic acquisitions to enhance its market position [14][34]

Core Insights - Arteris has completed the acquisition of Cycuity, enhancing its product portfolio to secure data movement from AI data centers to edge devices through advanced semiconductor cybersecurity technology [1][3] Industry Overview - The need for semiconductor cybersecurity assurance is increasing as the threat landscape has expanded to the hardware layer, with reported new Common Vulnerabilities and Exposures (CVEs) in hardware growing over 15 times in the last five years [2] - The rise of AI and chiplets has accelerated the trend of silicon vulnerabilities, necessitating technology solutions that enhance semiconductor security without compromising system-on-chip (SoC) functionality, performance, and schedules [2] Company Strategy - By integrating Arteris's innovative system IP with Cycuity's silicon hardware security assurance technology, the acquisition positions Arteris to address hardware security concerns effectively [3] - The acquisition aims to broaden Arteris's commitment to delivering comprehensive products and solutions that facilitate secure on-chip data movement, particularly in the context of increasing cyberattacks targeting unsecured data [3] Company Profile - Arteris is recognized as a leading provider of semiconductor technology, focusing on high-performance, power-efficient silicon with built-in safety, reliability, and security [4] - The company's products are designed to optimize data movement and reduce complexity in the AI era, utilizing network-on-chip (NoC) interconnect intellectual property (IP) and system-on-chip (SoC) software for integration automation and hardware security assurance [4]

Core Viewpoint - Arteris, Inc. has announced a definitive agreement to acquire Cycuity, Inc., enhancing its semiconductor cybersecurity capabilities to address increasing cyber threats in the semiconductor industry [1][2]. Company Overview - Arteris, Inc. is a leading provider of system IP for semiconductor creation, focusing on high-performance and power-efficient silicon solutions [5]. - Cycuity, Inc. specializes in hardware security assurance for semiconductor devices, addressing vulnerabilities that are increasingly targeted by cyberattacks [6]. Acquisition Details - The acquisition of Cycuity is expected to strengthen Arteris' product portfolio, particularly in improving data movement security in chiplets and SoCs [1][2]. - The transaction is subject to customary closing conditions and is anticipated to close in the first quarter of Arteris' fiscal year 2026 [4]. Industry Context - The need for hardware security in semiconductor designs has become critical due to the growing threat landscape, with reported new Common Vulnerabilities and Exposures (CVEs) in hardware increasing by over 15 times in the last five years [2]. - The expansion of hardware security vulnerabilities has broadened the attack surface, necessitating a trustworthy silicon foundation for electronic systems [3]. Product Integration - Cycuity's products are designed to mitigate security vulnerabilities throughout the SoC hardware development cycle, ensuring comprehensive protection from chips to software applications [3]. - The integration of Cycuity's technology with Arteris' products will enable semiconductor designers to identify and resolve security risks before silicon implementation and production [3].

Core Insights - Premarket trading is showing notable activity with significant price movements indicating potential trading opportunities before the market opens [1] Premarket Gainers - Cemtrex, Inc. (CETX) has increased by 284% to $11.79 - Treasure Global Inc. (TGL) has risen by 135% to $59.83 - Top Wealth Group Holding Limited (TWG) is up 95% at $11.73 - Fulcrum Therapeutics, Inc. (FULC) has gained 49% to $13.29 - MetaVia Inc. (MTVA) is up 33% at $10.90 - Kymera Therapeutics, Inc. (KYMR) has increased by 31% to $87.58 - Confluent, Inc. (CFLT) is up 27% at $29.40 - Immix Biopharma, Inc. (IMMX) has risen by 23% to $6.85 - Nurix Therapeutics, Inc. (NRIX) is up 18% at $21.46 - SU Group Holdings Limited (SUGP) has increased by 15% to $6.44 [3] Premarket Losers - SMX (Security Matters) Public Limited Company (SMX) has decreased by 27% to $242.01 - Meihua International Medical Technologies Co., Ltd. (MHUA) is down 27% at $10.20 - Polyrizon Ltd. (PLRZ) has declined by 16% to $10.90 - Fly-E Group, Inc. (FLYE) is down 16% at $6.90 - Sensei Biotherapeutics, Inc. (SNSE) has decreased by 14% to $8.29 - Kentucky First Federal Bancorp (KFFB) is down 10% at $4.00 - Arteris, Inc. (AIP) has declined by 7% to $16.27 - Fusion Fuel Green PLC (HTOO) is down 6% at $3.89 - Kamada Ltd. (KMDA) has decreased by 5% to $6.69 - iOThree Limited (IOTR) is down 5% at $3.11 [4]

Market Overview - U.S. stock futures showed mixed results, with Dow futures decreasing approximately 0.1% on Monday [1] Company-Specific Movements - Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) announced its delisting from Nasdaq, leading to a significant pre-market decline of 32.9%, bringing shares down to $9.41 [1] - SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares fell 17.2% to $275.00 after a substantial increase of 135% on the previous Friday [3] - Gulf Resources, Inc. (NASDAQ:GURE) saw a decline of 16.1% to $6.87 following a 4% drop on Friday [3] - Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) shares decreased by 16.1% to $5.35 after a notable surge of 98% on Friday [3] - Fly-E Group, Inc. (NASDAQ:FLYE) experienced a 14.4% drop to $7.08 after receiving a delinquency notice from Nasdaq regarding a delayed Form 10-Q [3] - Ecarx Holdings Inc. (NASDAQ:ECX) shares fell 9.1% to $1.91 after an 8% gain on Friday [3] - Arteris Inc (NASDAQ:AIP) saw a decline of 7.1% to $16.30 in pre-market trading [3] - Veracyte Inc (NASDAQ:VCYT) shares decreased by 5.7% to $42.06 after a 6% decline on Friday [3] - Chagee Holdings Ltd (NASDAQ:CHA) shares fell 4.6% to $13.91 in pre-market trading [3] - PureTech Health PLC (NASDAQ:PRTC) experienced a 4.2% decline to $17.30, despite announcing a successful end-of-Phase 2 meeting with the FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis [3] - PepGen Inc (NASDAQ:PEPG) shares declined by 3.9% to $5.23 in pre-market trading [3]

Market Overview - U.S. stock futures showed mixed results, with Dow futures decreasing approximately 0.1% on Monday [1] Company-Specific Movements - Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) announced its delisting from Nasdaq, leading to a significant pre-market decline of 32.9%, bringing shares down to $9.41 [1] - SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares fell 17.2% to $275.00 after a substantial increase of 135% on the previous Friday [3] - Gulf Resources, Inc. (NASDAQ:GURE) saw a decline of 16.1% to $6.87 following a 4% drop on Friday [3] - Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) shares decreased by 16.1% to $5.35 after surging 98% on Friday [3] - Fly-E Group, Inc. (NASDAQ:FLYE) experienced a 14.4% drop to $7.08 after receiving a delinquency notice from Nasdaq regarding a delayed Form 10-Q [3] - Ecarx Holdings Inc. (NASDAQ:ECX) shares fell 9.1% to $1.91 after an 8% gain on Friday [3] - Arteris Inc (NASDAQ:AIP) saw a decline of 7.1% to $16.30 in pre-market trading [3] - Veracyte Inc (NASDAQ:VCYT) shares decreased by 5.7% to $42.06 after a 6% decline on Friday [3] - Chagee Holdings Ltd (NASDAQ:CHA) shares fell 4.6% to $13.91 in pre-market trading [3] - PureTech Health PLC (NASDAQ:PRTC) declined 4.2% to $17.30 despite announcing a successful end-of-Phase 2 meeting with the FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis [3] - PepGen Inc (NASDAQ:PEPG) shares decreased by 3.9% to $5.23 in pre-market trading [3]